Martin David Harp

Bangalore-based Eyestem will share more research findings on Eyecyte-RPE at this year's Association for Research in Vision and Ophthalmology meeting

Ophthalmologists report that dry eye syndrome, myopia progression and other ocular pathologies have increased, especially among paediatric patient groups

Aldeyra previously received a CRL for its initial New Drug Application for reproxalap in November 2023

Both trials failed to meet their primary endpoints for treatment of age-related macular degeneration

AURN001 is Aurion Biotech's clinical-stage allogeneic cell therapy asset for corneal oedema secondary to corneal endothelial disease

The synthetic opsin was packaged into an optimised AAV2 gene therapy vector that targets human retinal bipolar cells.

The Combination OPT-302 with Aflibercept Study (COAST) evaluated sozinibercept 2 mg in combination with aflibercept 2 mg for wet age-related macular degeneration

The award recipients are leading research projects in India, Italy and Mexico

Urcosimod, formerly known as OK-101, showed clear statistical significance in multiple endpoints in a recently completed Phase 2 trial

The encapsulated cell therapy from Neurotech Pharmaceuticals is the first FDA-approved treatment for MacTel

Previously, Susvimo was called the Port Delivery System with ranibizumab in the United States

The approval of Syfovre makes it the first and only approved treatment for GA in Australia.

ARCATUS or ARVN001 was developed by Clearside Biomedical and commercialised in the Asia-Pacific region by Arctic Vision

The launch follows a CE Mark received in late 2024

Investigators reported that the trial demonstrated significant improvements in visual function and retinal structure for patients with optic neuritis

Highlights from the year, courtesy of our colleagues at Ophthalmology Times

Research indicates suppressive valacyclovir could help patients avoid keratitis and iritis flare-ups

Abdelrahman Elhusseiny, MD, MSc, discusses his AAO presentation on risk of posterior capsular rupture in fellow-eyes cataract surgery

Ciclosporin 0.1% eye drops solution will be marketed under the brand name Vevizye in the EU for the treatment of dry eye disease

Dr Yorston delivered the Gisbert Richard Lecture at this year's EURETINA Congress

Srinivas R. Sadda, MD, spoke about the EURETINA meeting, his presentation on ultra widefield imaging, and the value of the international community of retina clinicians connecting in person at meetings. The interview took place at the EURETINA 2024 meeting held in Barcelona, Spain, on September 19-22, 2024.

Taiji Sakamoto, MD, PhD, spoke about being a board member of EURETINA and his motivations to be a part of the cooperative work that is a hallmark of EURETINA. The interview took place at the EURETINA 2024 meeting held in Barcelona, Spain, on September 19-22, 2024.

Neltependocel has received both regulatory and reimbursement approval in Japan

Timothy L Jackson PhD, MB ChB, FRCOphth, speaks about a combination therapy for VEGF-A/C/D inhibition with sozinibercept and ranibizumab

The agency confirmed its June 2024 negative opinion after Apellis requested re-examination of the EMA's initial response

Veeral Sheth, MD, MBA, FASRS, FACS, discusses outcomes from the Phase 1 HELIOS trial

New research and EURETINA highlights from the director of the "underdog" eye clinic

How retinal imaging can provide clinicians a deeper understanding of myopia

Yousif Subhi, MD, PhD, discusses his Ophthalmologica Lecture, "Things That Matter: An Evidence-Based Approach to AMD and CSC"

Why having a set process for diagnostic imaging is crucial to patient outcomes